Lorin Randall - 10 Jun 2022 Form 4 Insider Report for ACORDA THERAPEUTICS INC (ACOR)

Role
Director
Signature
/s/ Lorin J. Randall
Issuer symbol
ACOR
Transactions as of
10 Jun 2022
Transactions value $
$0
Form type
4
Filing time
14 Jun 2022, 08:19:50 UTC
Previous filing
15 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACOR Non-Employee Stock Option Award $0 +10,000 $0 10,000 10 Jun 2022 Common Stock 10,000 $0.3699 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option vest in four equal quarterly installments over 12 months beginning on June 10, 2022, with the first quarterly installment vesting on September 10, 2022.